The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2019 | New Horizons in PNH
Regis Peffault de Latour
• 15 Jun 2019
Regis Peffault de Latour, MD, PhD, Saint Louis Hospital, Paris, France, discusses up-and-coming therapies for paroxysmal nocturnal hemoglobinuria (PNH). This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
